A141

The aim of this study was to investigate the quantitative changes in the phospholipid (PL) content of peripheral blood mononuclear cells (MNC), plasma membrane (PM), fraction in breast (BC) and cervical cancers (CC) compared to normal levels. Eight PL fractions were identified by TLC method in the P...

Full description

Bibliographic Details
Main Authors: H. Davtyan, G. Hakobyan, K. Alexsanyan, Y. Tadevosyan
Format: Article
Language:English
Published: Elsevier 2015-11-01
Series:EJC Supplements
Online Access:http://www.sciencedirect.com/science/article/pii/S1359634915000221
_version_ 1818108393618931712
author H. Davtyan
G. Hakobyan
K. Alexsanyan
Y. Tadevosyan
author_facet H. Davtyan
G. Hakobyan
K. Alexsanyan
Y. Tadevosyan
author_sort H. Davtyan
collection DOAJ
description The aim of this study was to investigate the quantitative changes in the phospholipid (PL) content of peripheral blood mononuclear cells (MNC), plasma membrane (PM), fraction in breast (BC) and cervical cancers (CC) compared to normal levels. Eight PL fractions were identified by TLC method in the PM of MNC, namely: lysophosphatidylcholines (LPC), sphingomyelins (SPM), phosphatidylcholines (PC), phosphatidylinositols (PI), phosphatidylserines (PS), phosphatidylethanolamines (PE), phosphatidic acids (PA) and diphosphatidylglycerols (DPG). Data obtained indicate that all PLs, quantified in this study, were significantly altered in blood MNC of cancer patients compared to healthy individuals. It was shown that compared to norm levels of LPC, PC, PE fractions were reliable increased in BC and CC, when PI, PS, PA – decreased. Notably, regular disturbances reveled in BC and CC were identical with those observed earlier in chronic lymphocytic leukemia and also distinctly individual for each patient. We conclude that alterations in PLs content of crude MNC PMs have been associated with disease pathology and similarly involved in the onset and evolution of diverse forms of cancer. These data can be useful for prospective biomarkers selection and cancer definition as well as for discovery of new personalized treatment modes.
first_indexed 2024-12-11T02:14:39Z
format Article
id doaj.art-837f83c135624172a507fc864bac56e2
institution Directory Open Access Journal
issn 1359-6349
language English
last_indexed 2024-12-11T02:14:39Z
publishDate 2015-11-01
publisher Elsevier
record_format Article
series EJC Supplements
spelling doaj.art-837f83c135624172a507fc864bac56e22022-12-22T01:24:12ZengElsevierEJC Supplements1359-63492015-11-011311210.1016/j.ejcsup.2015.08.021A141H. Davtyan0G. Hakobyan1K. Alexsanyan2Y. Tadevosyan3Institute of Molecular Biology, NAS RA, Yerevan, ArmeniaInstitute of Molecular Biology, NAS RA, Yerevan, ArmeniaNational Center of Oncology after V.Fanarjyan, MH RA, Yerevan, ArmeniaInstitute of Molecular Biology, NAS RA, Yerevan, ArmeniaThe aim of this study was to investigate the quantitative changes in the phospholipid (PL) content of peripheral blood mononuclear cells (MNC), plasma membrane (PM), fraction in breast (BC) and cervical cancers (CC) compared to normal levels. Eight PL fractions were identified by TLC method in the PM of MNC, namely: lysophosphatidylcholines (LPC), sphingomyelins (SPM), phosphatidylcholines (PC), phosphatidylinositols (PI), phosphatidylserines (PS), phosphatidylethanolamines (PE), phosphatidic acids (PA) and diphosphatidylglycerols (DPG). Data obtained indicate that all PLs, quantified in this study, were significantly altered in blood MNC of cancer patients compared to healthy individuals. It was shown that compared to norm levels of LPC, PC, PE fractions were reliable increased in BC and CC, when PI, PS, PA – decreased. Notably, regular disturbances reveled in BC and CC were identical with those observed earlier in chronic lymphocytic leukemia and also distinctly individual for each patient. We conclude that alterations in PLs content of crude MNC PMs have been associated with disease pathology and similarly involved in the onset and evolution of diverse forms of cancer. These data can be useful for prospective biomarkers selection and cancer definition as well as for discovery of new personalized treatment modes.http://www.sciencedirect.com/science/article/pii/S1359634915000221
spellingShingle H. Davtyan
G. Hakobyan
K. Alexsanyan
Y. Tadevosyan
A141
EJC Supplements
title A141
title_full A141
title_fullStr A141
title_full_unstemmed A141
title_short A141
title_sort a141
url http://www.sciencedirect.com/science/article/pii/S1359634915000221
work_keys_str_mv AT hdavtyan a141
AT ghakobyan a141
AT kalexsanyan a141
AT ytadevosyan a141